Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.
about
Attenuation of Pulmonary Ischemia-Reperfusion Injury by Adenosine A2B Receptor AntagonismEx Vivo Perfusion With Adenosine A2A Receptor Agonist Enhances Rehabilitation of Murine Donor Lungs After Circulatory Death.Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysmsAdenosine A1 receptor activation attenuates lung ischemia-reperfusion injury.Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury.Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function.Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation modelTargeting of adenosine receptors in ischemia-reperfusion injury.Tissue-derived proinflammatory effect of adenosine A2B receptor in lung ischemia-reperfusion injury.Oxidative and nitrosative stress during pulmonary ischemia-reperfusion injury: from the lab to the ORAdenosine receptor targeting in health and disease.Protein phosphatase 2A activation attenuates inflammation in murine models of acute lung injury.A New Class of Fluorinated A2A Adenosine Receptor Agonist with Application to Last-Step Enzymatic [18 F]Fluorination for PET Imaging.Lung injury pathways: Adenosine receptor 2B signaling limits development of ischemic bronchiolitis obliterans organizing pneumonia.Heart injury following intestinal ischemia reperfusion in rats is attenuated by association of ischemic preconditioning and adenosine.Purinergic Regulation of Neutrophil Function.Increasing circulating sphingosine-1-phosphate attenuates lung injury during ex vivo lung perfusion.
P2860
Q30276921-5E3E1DC1-C3B2-4299-B8C3-6E289B75B453Q30278868-C0D91A89-3CDF-47BC-BE6B-971A2C6342BBQ30412759-0B801764-1A3F-4A3E-852F-FB76EFA60731Q30412838-389AD0CE-B712-4AB5-859F-629DC5735283Q30413271-A55BF34F-3A7C-41C2-9130-24FB6A38D586Q30416644-6C030C50-9278-4AA1-8A23-A7F5CF80521BQ30424759-D8C18564-5E72-43B3-93B3-DD410B66E8D6Q30429069-5106E163-D36E-414D-ABE6-4CC75FF9412EQ30430492-2C19BE21-33A5-4EB1-B08B-CF522937152AQ33575342-4A999BF6-5EFD-4832-9F79-86738253659FQ37948081-99FCBC54-2C73-4559-8BA3-9D2EC9DBDA2CQ38734326-77963958-E969-46BB-A793-FB0B1EE9FBA6Q47888564-DAA1EB4F-900E-4F0B-8C1F-3F1BF8470EC2Q47953113-9C7DEFEF-8CEA-41C8-BB73-175357351DF0Q51052892-E56F59B2-F0B8-4399-BC55-5CFE6068863CQ52353629-C51BA340-9EF2-4809-95E5-B11B62B3BA67Q54118155-DFD28D79-5B40-417D-8B27-F42FA8FE4792
P2860
Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Activation of A1, A2A, or A3 a ...... g ischemia-reperfusion injury.
@ast
Activation of A1, A2A, or A3 a ...... g ischemia-reperfusion injury.
@en
type
label
Activation of A1, A2A, or A3 a ...... g ischemia-reperfusion injury.
@ast
Activation of A1, A2A, or A3 a ...... g ischemia-reperfusion injury.
@en
prefLabel
Activation of A1, A2A, or A3 a ...... g ischemia-reperfusion injury.
@ast
Activation of A1, A2A, or A3 a ...... g ischemia-reperfusion injury.
@en
P2093
P2860
P1476
Activation of A1, A2A, or A3 a ...... g ischemia-reperfusion injury.
@en
P2093
Dustin M Walters
Eric B Unger
Joel Linden
Leo M Gazoni
P2860
P304
P356
10.1016/J.JTCVS.2010.03.002
P407
P577
2010-04-15T00:00:00Z